Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-12-02

Clinical Trial Update: To Evaluate The Effect Of Ketoconazole, Ritonavir and Erythromycin on the Safety and Pharmacokinetics of Avanafil [Phase 1]

View source ↗

Summary

Phase 1 trial assessing how ketoconazole, ritonavir, and erythromycin affect the safety and pharmacokinetics of avanafil for erectile dysfunction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AVANAFIL (AVANAFIL)
  • ERYTHROMYCIN (ERYTHROMYCIN)
  • Ketoconazole (Ketoconazole)
  • Ritonavir (Ritonavir)

Snippet

Sponsor: VIVUS LLC | Conditions: Erectile Dysfunction | Phase 1 | Status: COMPLETED